Chicago, IL, United States of America

Bi-Shun Zeng


Average Co-Inventor Count = 2.4

ph-index = 6

Forward Citations = 55(Granted Patents)


Company Filing History:


Years Active: 2016-2020

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Bi-Shun Zeng: Innovator in Heteroyohimbine Alkaloids

Introduction

Bi-Shun Zeng is a prominent inventor based in Chicago, IL (US). He has made significant contributions to the field of chemistry, particularly in the synthesis of complex natural products. With a total of 6 patents to his name, Zeng's work is recognized for its innovative approaches and practical applications.

Latest Patents

Zeng's latest patents focus on the enantioselective syntheses of heteroyohimbine natural product intermediates. His work includes the enantioselective syntheses of cis- and trans-bicyclic dihydropyran compounds, which are crucial intermediates in the production of heteroyohimbine alkaloids. These patents highlight his expertise in developing efficient synthetic routes for complex organic molecules.

Career Highlights

Bi-Shun Zeng is affiliated with Northwestern University, where he conducts research and collaborates with other scientists. His academic background and research endeavors have positioned him as a leading figure in his field. Zeng's innovative work has not only advanced scientific knowledge but also contributed to practical applications in pharmaceuticals.

Collaborations

Zeng has worked alongside notable colleagues, including Karl A. Scheidt and Ashkaan Younai. These collaborations have fostered a dynamic research environment, leading to groundbreaking discoveries and advancements in synthetic chemistry.

Conclusion

Bi-Shun Zeng's contributions to the field of chemistry, particularly in the synthesis of heteroyohimbine alkaloids, demonstrate his innovative spirit and dedication to research. His work continues to inspire future generations of scientists and inventors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…